A comprehensive view of Moderna Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Bioeconomy Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
David Rubenstein joins Moderna's Board of Directors, replacing Stephen Berenson; Robert Langer also retiring from the board, recruitment for his replacement ongoing
Published:
July 23, 2024
by Moderna Inc.
|
Moderna addresses 'triple demic' threat of RSV, flu, COVID-19; company educates on mRNA's role in vaccine innovation through webinars, blog posts
Published:
July 19, 2024
by Industry Intelligence Inc.
|
Moderna to report Q2 2024 financial results on August 1, 2024; company to host live conference call and webcast at 8:00 a.m. ET
Published:
July 10, 2024
by Moderna Inc.
|
Moderna and Mitsubishi Tanabe Pharma to promote mRNA respiratory vaccines in Japan, including COVID-19; agreement valid until March 31, 2029, covers manufacturing, sales, and distribution
Published:
July 08, 2024
by Moderna Inc.
|
Moderna Inc. expands biotech leadership with strategic presence at UK's Harwell Science and Innovation Campus; initiative includes constructing Moderna Innovation and Technology Centre
Published:
July 05, 2024
by Industry Intelligence Inc.
|
Ask us about our Bioeconomy market view
Trending Chart
Interactive chart with headline count